Biologic Reconstruction With a Motorized Intramedullary Bone Transport Nail After Tumor Resection.
Journal
Journal of orthopaedic trauma
ISSN: 1531-2291
Titre abrégé: J Orthop Trauma
Pays: United States
ID NLM: 8807705
Informations de publication
Date de publication:
01 Oct 2021
01 Oct 2021
Historique:
accepted:
09
03
2021
entrez:
17
9
2021
pubmed:
18
9
2021
medline:
26
10
2021
Statut:
ppublish
Résumé
Distraction osteogenesis is an option for reconstruction of intercalary defects. The use of bone transport after tumor surgery has been limited because of concerns of pin tract infections with external fixation and the theoretical risk of causing tumor growth. The effects of chemotherapy and radiation on the regenerate and healing of the docking site are also not well studied, but the current literature has mostly favorable outcomes with no evidence of causing tumor proliferation. The Precice bone transport nail offers a noninvasive method of distraction osteogenesis, which eliminates the need for prolonged external fixation and the risk of pin tract infections. This report discusses the technique for using the Precice bone transport nail after tumor resection. Bone transport may be considered for intercalary defects after en bloc resection of sarcoma, metastatic disease, and benign aggressive bone tumors. The use of distraction osteogenesis after tumor resection is a promising technique for the biologic reconstruction of intercalary defects.
Identifiants
pubmed: 34533483
doi: 10.1097/BOT.0000000000002118
pii: 00005131-202110004-00006
doi:
Substances chimiques
Biological Products
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
S25-S30Informations de copyright
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Références
Gutowski CJ, Basu-Mallick A, Abraham JA. Management of bone sarcoma. Surg Clin North Am. 2016;96:1077–1106.2.
Zou C, Lin T, Wang B, et al. Managements of giant cell tumor within the distal radius: a retrospective study of 58 cases from a single center. J Bone Oncol. 2018;14:100211.
Higuchi T, Yamamoto N, Hayashi K, et al. Long-term patient survival after the surgical treatment of bone and soft-tissue metastases from renal cell carcinoma. Bone Joint J. 2018;100B:1241–1248.
Higuchi T, Yamamoto N, Hayashi K, et al. The efficacy of wide resection for musculoskeletal metastatic lesions of renal cell carcinoma. Anticancer Res. 2018;38:577–582.
Kato S, Murakami H, Demura S, et al. The impact of complete surgical resection of spinal metastases on the survival of patients with thyroid cancer. Cancer Med. 2016;5:2343–2349.
You D, Lee C, Jeong IG, et al. Impact of metastasectomy on prognosis in patients treated with targeted therapy for metastatic renal cell carcinoma. J Cancer Res Clin Oncol. 2016;142:2331–2338.
Zaid HB, Parker WP, Safdar NS, et al. Outcomes following complete surgical metastasectomy for patients with metastatic renal cell carcinoma: a systematic review and meta-analysis. J Urol. 2017;197:44–49.
Takeuchi A, Yamamoto N, Hayashi K, et al. Joint-preservation surgery for pediatric osteosarcoma of the knee joint. Cancer Metastasis Rev. 2019;38:709–722.
Sato W, Okazaki H, Goto T. Leg lengthening as a means of improving ambulation following an internal hemipelvectomy. Case Rep Orthop. 2016;2016:7089142.
Singhania AK, Lovisetti L, Maguire J, et al. Use of the Ilizarov technique to improve limb function following hemipelvectomy. Eur J Surg Oncol. 2003;29:64–68.
Catagani MA, Ottaviani G. Ilizarov method to correct limb length discrepancy after limb-sparing hemipelvectomy. J Pediatr Orthop B. 2008;17:293–298.
Kang S, Lee JS, Park J, et al. Staged lengthening and reconstruction for children with a leg-length discrepancy after excision of an osteosarcoma around the knee. Bone Joint J. 2017;99B:401–408.
Pilge H, Ruppert M, Bittersohl B, et al. Lengthening of newly formed humerus after autologous fibula graft transplantation following intercalary tumor resection. J Pediatr Orthop B. 2018;27:322–325.
Muratori F, Scoccianti G, Beltrami G, et al. Is an intramedullary nail a valid treatment for limb-length discrepancy after bone tumor resection? Case descriptions. Surg Technol Int. 2018;33:281–288.
Vercio RC, Shields TG, Zuckerman LM. Use of magnetic growing intramedullary nails in compression during intercalary allograft reconstruction. Orthopedics. 2018;41:330–335.
Lesensky J, Prince DE. Distraction osteogenesis reconstruction of large segmental bone defects after primary tumor resection: pitfalls and benefits. Eur J Orthop Surg Traumatol. 2017;27:715–727.
Olesen UK, Nygaard T, Prince DE, et al. Plate-assisted bone segment transport with motorized lengthening nails and locking plates: a technique to treat femoral and tibial bone defects. J Am Acad Orthop Surg Glob Res Rev. 2019;3:e064.
Momeni A, Januszyk M, Wan DC. Is distraction osteogenesis of the irradiated craniofacial skeleton contraindicated? J Craniofac Surg. 2017;28:1236–1241.
Kashiwa K, Kobayashi S, Nohara T, et al. Efficacy of distraction osteogenesis for mandibular reconstruction in previously irradiated areas: clinical experiences. J Craniofac Surg. 2008;19:1571–1576.
Kashiwa K, Kobayashi S, Honda T, et al. Alveolar reconstruction by distraction osteogenesis under unfavorable conditions. J Craniofac Surg. 2010;21:1810–1812.
Matsubara H, Tsuchiya H, Sakurakichi K, et al. Distraction osteogenesis of a previously irradiated femur with malignant lymphoma: a case report. J Orthop Sci. 2005;10:430–435.
Gabriel A, Maxwell GP. AlloDerm RTU integration and clinical outcomes when used for reconstructive breast surgery. Plast Reconstr Surg Glob Open. 2018;6:e1744.
Stine KC, Wahl EC, Liu L, et al. Cisplatin inhibits bone healing during distraction osteogenesis. J Orthop Res. 2014;32:464–470.
He X, Zhang HL, Hu YC. Limb salvage by distraction osteogenesis for distal tibial osteosarcoma in a young child: a case report. Orthop Surg. 2016;8:253–256.
Yang Z, Tao H, Ye Z, et al. Bone transport for reconstruction of large bone defects after tibial tumor resection: a report of five cases. J Int Med Res. 2018;46:3219–3225.
Omae K, Tsujimoto Y, Honda M, et al. Comparative efficacy and safety of bone-modifying agents for the treatment of bone metastases in patients with advanced renal cell carcinoma: a systematic review and meta-analysis. Oncotarget. 2017;8:68890–68898.
Cui X, Li S, Gu J, et al. Retrospective study on the efficacy of bisphosphonates in tyrosine kinase inhibitor-treated patients with non-small cell lung cancer exhibiting bone metastasis. Oncol Lett. 2019;18:5437–5447.
Wong ECL, Kapoor A. Does bone-targeted therapy benefit patients with metastatic renal cell carcinoma? Transl Oncol. 2019;13:241–244.
Gnant M, Pfeiler G, Steger GG, et al. Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2019;20:339–351.
Savvidou OD, Bolia IK, Chloros GD. Denosumab: current use in the treatment of primary bone tumors. Orthopedics. 2017;40:204–210.
Kiely P, Ward K, Bellemore CM, et al. Bisphosphonate rescue in distraction osteogenesis: a case series. J Pediatr Orthop. 2007;27:467–471.
Piperno-Neumann S, Le Deley MC, Rédini F, et al. Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial. Lancet Oncol. 2016;17:1070–1080.
Li S, Chen P, Pei Y, et al. Addition of Zoledronate to chemotherapy in patients with osteosarcoma treated with limb-sparing surgery: a phase III clinical trial. Med Sci Monit. 2019;25:1429–1438.
Hatzokos I, Stavridis SI, Iosifidou E, et al. Autologous bone marrow grafting combined with demineralized bone matrix improves consolidation of docking site after distraction osteogenesis. J Bone Joint Surg Am. 2011;93:671–678.
Geller DS, Singh MY, Zhang W, et al. Development of a model system to evaluate local recurrence in osteosarcoma and assessment of the effects of bone morphogenetic protein-2. Clin Cancer Res. 2015;21:3003–3012.
Gill J, Connolly P, Roth M, et al. The effect of bone morphogenetic protein-2 on osteosarcoma metastasis. PLoS One. 2017;12:e0173322.
Tian H, Zhou T, Chen H, et al. Bone morphogenetic protein-2 promotes osteosarcoma growth by promoting epithelial-mesenchymal transition (EMT) through the Wnt/β-catenin signaling pathway. J Orthop Res. 2019;37:1638–1648.
Delloye C, Suratwala SJ, Cornu O, et al. Treatment of allograft nonunions with recombinant human bone morphogenetic proteins (rhBMP). Acta Orthop Belg. 2004;70:591–597.
Matsubara H, Tsuchiya H. Treatment of bone tumor using external fixator. J Orthop Sci. 2019;24:1–8.